Fatty liver linked to skin disease psoriasis

Credit: CC0 Public Domain

Scientists from Chung Shan Medical University found a link between nonalcoholic fatty liver disease (NAFLD) and psoriasis, especially for patients younger than 40 years.

The research is published in Frontiers in Immunology and was conducted by Shuo-Yan Gau et al.

Psoriasis is a skin disease that causes red, itchy scaly patches, most commonly on the knees, elbows, trunk and scalp.

Psoriasis is a common, long-term (chronic) disease with no cure. It tends to go through cycles, flaring for a few weeks or months, then subsiding for a while or going into remission.2 May 2020.

NAFLD is the accumulation of liver fat in people who drink little or no alcohol.

The cause of NAFLD is unknown. Risk factors include obesity, gastric bypass surgery, high cholesterol and type 2 diabetes.

In the study, the team analyzed data from Taiwan’s National Health Insurance Research Database to examine the bidirectional association between NAFLD and psoriasis.

The team found a strongly increased risk for developing psoriasis for patients with NAFLD while for younger patients with NAFLD.

For new psoriasis patients, the risk for developing NAFLD in the future was much higher compared with those without psoriasis.

In addition, the risk was higher for patients in younger psoriasis subgroups younger than age 40 years versus those in older subgroups.

The team says future studies should consider the mechanism influencing the pathogenesis and correlation between NAFLD and psoriasis and focus on the difference between different psoriasis severity subgroups.

If you care about liver diseases, please read studies about green diet that could strongly lower non-alcoholic fatty liver disease, https://knowridge.com/2020/08/common-fatty-liver-disease-may-cause-alzheimers-like-symptoms/and this seaweed may prevent obesity, fatty liver disease.

For more information about fatty livers, please see recent studies that aerobic exercise could have the final say on fatty livers, and results showing a new therapy for fatty liver disease.

Copyright © 2022 Knowridge Science Report. All rights reserved.